XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2022 $ 75,394 $ 5 $ 24 $ 495,818 $ (12,173) $ (409,381) $ 1,101
Beginning Balances (in shares) at Dec. 31, 2022   5,000 22,623        
Net loss (3,863)         (3,863)  
Unrealized income (loss) from foreign currency translation adjustments 101           101
Issuance of common stock in connection with vesting of stock awards (shares)     254        
Stock-based compensation 1,984     1,984      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (284)       (284)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (40)        
Proceeds from exercise of warrants 963     963      
Proceeds from exercise of warrants, (shares)     275        
Ending Balances at Jun. 30, 2023 74,295 $ 5 $ 24 498,765 (12,457) (413,244) 1,202
Ending Balances (in shares) at Jun. 30, 2023   5,000 23,112        
Beginning Balances at Mar. 31, 2023 73,601 $ 5 $ 24 496,808 (12,357) (412,100) 1,221
Beginning Balances (in shares) at Mar. 31, 2023   5,000 22,677        
Net loss (1,144)         (1,144)  
Unrealized income (loss) from foreign currency translation adjustments (19)           (19)
Issuance of common stock in connection with vesting of stock awards (shares)     176        
Stock-based compensation 994     994      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (100)       (100)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (16)        
Proceeds from exercise of warrants 963     963      
Proceeds from exercise of warrants, (shares)     275        
Ending Balances at Jun. 30, 2023 74,295 $ 5 $ 24 498,765 (12,457) (413,244) 1,202
Ending Balances (in shares) at Jun. 30, 2023   5,000 23,112        
Beginning Balances at Dec. 31, 2023 74,272 $ 5 $ 25 500,752 (12,969) (414,870) 1,329
Beginning Balances (in shares) at Dec. 31, 2023   5,000 23,247        
Net loss (10,774)         (10,774)  
Unrealized income (loss) from foreign currency translation adjustments (394)           (394)
Issuance of common stock in connection with vesting of stock awards (shares)     288        
Stock-based compensation 2,494     2,494      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (541)       (541)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (87)        
Ending Balances at Jun. 30, 2024 65,057 $ 5 $ 25 503,246 (13,510) (425,644) 935
Ending Balances (in shares) at Jun. 30, 2024   5,000 23,448        
Beginning Balances at Mar. 31, 2024 70,166 $ 5 $ 25 501,771 (13,246) (419,428) 1,039
Beginning Balances (in shares) at Mar. 31, 2024   5,000 23,334        
Net loss (6,216)         (6,216)  
Unrealized income (loss) from foreign currency translation adjustments (104)           (104)
Issuance of common stock in connection with vesting of stock awards (shares)     168        
Stock-based compensation 1,475     1,475      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (264)       (264)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (54)        
Ending Balances at Jun. 30, 2024 $ 65,057 $ 5 $ 25 $ 503,246 $ (13,510) $ (425,644) $ 935
Ending Balances (in shares) at Jun. 30, 2024   5,000 23,448